Cochlear Limited (ASX:COH) Declares Final Dividend of $1.75

Cochlear Limited (ASX:COHGet Free Report) announced a final dividend on Thursday, September 14th, MarketIndexAU reports. Investors of record on Tuesday, October 10th will be paid a dividend of 1.75 per share on Tuesday, October 10th. This represents a yield of 0.66%. The ex-dividend date of this dividend is Sunday, September 17th. This is a positive change from Cochlear’s previous final dividend of $1.45.

Cochlear Price Performance

The company has a debt-to-equity ratio of 11.54, a quick ratio of 1.93 and a current ratio of 2.36.

Insider Buying and Selling

In related news, insider Christine McLoughlin bought 250 shares of the business’s stock in a transaction dated Thursday, August 31st. The shares were purchased at an average cost of A$271.22 ($174.98) per share, with a total value of A$67,805.00 ($43,745.16). In related news, insider Dig Howitt sold 6,000 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of A$264.96 ($170.94), for a total transaction of A$1,589,760.00 ($1,025,651.61). Also, insider Christine McLoughlin acquired 250 shares of the company’s stock in a transaction that occurred on Thursday, August 31st. The shares were acquired at an average cost of A$271.22 ($174.98) per share, for a total transaction of A$67,805.00 ($43,745.16). Insiders have bought a total of 527 shares of company stock valued at $127,086 over the last ninety days. Company insiders own 0.49% of the company’s stock.

Cochlear Company Profile

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Read More

Dividend History for Cochlear (ASX:COH)

Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with's FREE daily email newsletter.